07 Feb 2023
Lupuzor Trial Update
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Lupuzor Trial Update
ImmuPharma plc (IMM:LON) | 2.4 0 4.9% | Mkt Cap: 9.79m
- Published:
07 Feb 2023 -
Author:
Stanford Capital Research Team -
Pages:
4